JP Patent

JP6137833B2 — 脱髄性および他の神経系疾患を患っている患者における神経認知的および／または神経精神医学的障害を改善するための４−アミノピリジンの使用

Assigned to Acorda Therapeutics Inc · Expires 2017-05-31 · 9y expired

What this patent protects

Patent listed against Xcopri.

Drugs covered by this patent

Patent Metadata

Patent number
JP6137833B2
Jurisdiction
JP
Classification
—
Expires
2017-05-31
Drug substance claim
No
Drug product claim
No
Assignee
Acorda Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.